How Does GLP-1 Work? The Mechanism Behind Ozempic Explained

GLP-1 (glucagon-like peptide-1) is a hormone your gut releases after you eat. It tells the pancreas to release insulin, lowers blood sugar, slows how fast your stomach empties, and signals your brain that you are full. Ozempic (semaglutide) is a synthetic copy of this hormone, called a GLP-1 receptor agonist, that lasts far longer in the body than the natural version. That is why one weekly injection can manage blood sugar and reduce appetite.

How does GLP-1 work?

GLP-1 binds to receptors on cells in the pancreas, gut, and brain. When it activates those receptors, it triggers four linked effects: more insulin when blood sugar is high, less glucagon (the hormone that raises blood sugar), slower stomach emptying, and reduced hunger. Your body makes its own GLP-1, but it breaks down within minutes. Semaglutide is engineered to resist that breakdown, so its effects last about a week per dose.

Below is the mechanism broken into five steps.

Step 1: Semaglutide binds to the GLP-1 receptor

Ozempic is built to mimic natural GLP-1 closely enough to fit the same receptor. According to the manufacturer's prescribing data, semaglutide selectively binds to and activates the GLP-1 receptor, the same target the natural hormone uses. Small structural changes to the molecule protect it from being cleared by the kidneys and from being broken down by enzymes, which is what results in it a half-life of roughly seven days instead of minutes.

Step 2: The pancreas releases insulin, but only when blood sugar is high

Once the receptor is active, the pancreas releases more insulin in response to a meal. The key detail is that the process is glucose-dependent. As Harvard Health explains, GLP-1 drugs prompt insulin release mainly when blood sugar is elevated, unlike injected insulin, which works regardless of the current level. Because of this, GLP-1 medications carry a lower risk of dangerously low blood sugar (hypoglycemia) than many older diabetes drugs.

Step 3: Glucagon goes down

At the same time, GLP-1 suppresses glucagon. Glucagon is the hormone that tells the liver to dump stored glucose into the blood. Mayo Clinic notes that semaglutide binds to GLP-1 receptors in the pancreas and suppresses glucagon release, which helps keep blood sugar from climbing. Like the insulin effect, this suppression is glucose-dependent, so it eases off when blood sugar is already low.

Step 4: The stomach empties more slowly

GLP-1 slows gastric emptying, meaning food leaves your stomach more gradually. Two things follow. First, glucose enters the bloodstream more slowly after a meal, which smooths out blood sugar spikes. Second, you feel full sooner and stay full longer, so you tend to eat less. This slower digestion is also why nausea is the most common side effect, especially early on.

Step 5: The brain dials down appetite

This process is the step that drives most of the weight loss. GLP-1 receptors sit in the hypothalamus and brainstem, the parts of the brain that regulate hunger and fullness. Mayo Clinic describes how activating these receptors reduces feelings of hunger, which lowers overall calorie intake. Many people report that constant food thoughts, sometimes called "food noise," quiet down. Eating less, along with the slower digestion from Step 4, produces sustained weight loss over months.

How does Ozempic cause weight loss?

Ozempic causes weight loss mainly by reducing appetite and slowing digestion, which together lead you to eat fewer calories. The brain effect (Step 5) and the slower stomach emptying (Step 4) are the two biggest drivers. The blood sugar effects help with diabetes but are not the main reason the scale moves. One important point of accuracy: Ozempic itself is FDA-approved for type 2 diabetes, not weight loss. The same molecule at a higher dose is sold as Wegovy and is approved for weight management. Prescribing Ozempic for weight loss alone is off-label.

What does the clinical trial evidence show?

The strongest weight-loss data come from the STEP 1 trial, published in the New England Journal of Medicine in 2021. Adults with overweight or obesity who took once-weekly semaglutide 2.4 mg (the Wegovy dose) plus lifestyle changes lost an average of 14.9% of their body weight over 68 weeks, compared with 2.4% in the placebo group. About 86% of people on semaglutide lost at least 5% of their body weight (Wilding et al., NEJM 2021).

The benefits go beyond weight. The SELECT trial, published in the New England Journal of Medicine in 2023, followed more than 17,000 people with overweight or obesity and existing heart disease but no diabetes. Over about three and a half years, semaglutide cut the risk of major cardiovascular events (heart attack, stroke, or cardiovascular death) by 20%, with an average weight loss of 9.4% (Lincoff et al., NEJM 2023).

How long does Ozempic take to work?

Blood sugar usually starts improving within the first week or two, because the insulin and glucagon effects begin quickly. Weight loss is slower. Doses are increased gradually over weeks to limit side effects, and most people notice meaningful weight change after the first couple of months. In STEP 1, weight loss continued for roughly a year before leveling off, so the full effect builds over many months rather than days.

What are the common side effects?

The most common side effects are gastrointestinal: nausea, vomiting, diarrhea, and constipation. They come directly from the slowed digestion in Step 4 and tend to be worst when starting or increasing the dose. For most people, they ease as the body adjusts, which is why doctors start low and titrate up slowly. Cleveland Clinic lists these gut symptoms as the typical side effects of GLP-1 agonists. Serious side effects are less common but can occur, so a clinician should always prescribe and monitor a GLP-1 medication.

Frequently asked questions

Is GLP-1 the same as Ozempic? No. GLP-1 is a natural hormone your body makes. Ozempic (semaglutide) is a manufactured drug that imitates it and lasts much longer in the body.

Does GLP-1 only help with diabetes? No. GLP-1 medications lower blood sugar in type 2 diabetes and reduce appetite, which supports weight loss. The SELECT trial also showed a 20% reduction in cardiovascular events.

Why does GLP-1 reduce hunger? GLP-1 activates receptors in the hypothalamus and brainstem, the brain regions that control fullness, so you feel satisfied with less food.

Is the weight loss permanent? Weight tends to return after stopping because the appetite-suppressing signal goes away. GLP-1 treatment is generally considered long-term, paired with diet and activity changes.

Medically reviewed by Baraa Alnahhal, MD | Healthcare Deserved | Last reviewed: June 2026. This article is for general education and is not medical advice. Talk to a licensed clinician before starting, stopping, or changing any medication.